Your institution may have access to this item. Find your institution then sign in to continue.
Title
Phase II study of vinorelbine in patients with malignant pleural mesothelioma.
Authors
Steele, J P; Shamash, J; Evans, M T; Gower, N H; Tischkowitz, M D; Rudd, R M
Abstract
To evaluate the response rate and impact on quality of life of vinorelbine given as cycles of 30 mg/m(2) weekly for 6 weeks to patients with malignant pleural mesothelioma.
Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Vol 18, Issue 23, p3912